Specifically, PRMT5-mediated methylation of G3BP2 at R468 enhances its stability, which in turn stabilizes ACLY activation, promoting de novo lipid synthesis and contributing to the progression of HNSCC [434]. Here, PRMT5 is linked to head and neck squamous cell carcinoma.